{
    "xml": "<topic id=\"PHP3612\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/pyrazinamide\" basename=\"pyrazinamide\" title=\"PYRAZINAMIDE\">\n<title>PYRAZINAMIDE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_192\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/pyrazinamide\">Pyrazinamide</xref>\n</p>\n<data name=\"vtmid\">13592004</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_574205566\" title=\"Antimycobacterials\">Antimycobacterials</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP39285\" outputclass=\"indicationsAndDose\" rev=\"1.31\" parent=\"/drugs/pyrazinamide\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Tuberculosis in combination with other drugs (standard unsupervised 6-month treatment)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight up to 50 kg)</p>\n<p>35&#8239;mg/kg once daily for 2 months (initial phase); maximum 1.5&#8239;g per day.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight 50 kg and above)</p>\n<p>35&#8239;mg/kg once daily for 2 months (initial phase); maximum 2&#8239;g per day.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 50 kg)</p>\n<p>1.5&#8239;g once daily for 2 months (initial phase).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50 kg and above)</p>\n<p>2&#8239;g once daily for 2 months (initial phase).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Tuberculosis in combination with other drugs (intermittent supervised 6-month treatment) (under expert supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight up to 50 kg)</p>\n<p>50&#8239;mg/kg 3 times a week (max. per dose 2&#8239;g 3 times a week) for 2 months (initial phase).</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child (body-weight 50 kg and above)</p>\n<p>50&#8239;mg/kg 3 times a week (max. per dose 2.5&#8239;g 3 times a week) for 2 months (initial phase).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 50 kg)</p>\n<p>2&#8239;g 3 times a week for 2 months (initial phase).</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50 kg and above)</p>\n<p>2.5&#8239;g 3 times a week for 2 months (initial phase).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39336\" outputclass=\"contraindications\" rev=\"1.8\" parent=\"/drugs/pyrazinamide\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Acute attack of gout</ph> (in adults)</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39362\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/drugs/pyrazinamide\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Diabetes</ph>; <ph outputclass=\"caution\">gout</ph> (in adults)</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39274\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/pyrazinamide\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (pyrazinamide).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39237\" outputclass=\"sideEffects\" rev=\"1.15\" parent=\"/drugs/pyrazinamide\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anorexia</ph>; <ph outputclass=\"sideEffect\">arthralgia</ph>; <ph outputclass=\"sideEffect\">dysuria</ph>; <ph outputclass=\"sideEffect\">fever</ph>; <ph outputclass=\"sideEffect\">flushing</ph> (in adults); <ph outputclass=\"sideEffect\">hepatomegaly</ph>; <ph outputclass=\"sideEffect\">hepatotoxicity</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">liver failure</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">sideroblastic anaemia</ph>; <ph outputclass=\"sideEffect\">splenomegaly</ph>; <ph outputclass=\"sideEffect\">thrombocytopenia</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39263\" outputclass=\"pregnancy\" parent=\"/drugs/pyrazinamide\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39380\" outputclass=\"breastFeeding\" parent=\"/drugs/pyrazinamide\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Amount too small to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39299\" outputclass=\"hepaticImpairment\" parent=\"/drugs/pyrazinamide\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Idiosyncratic hepatotoxicity more common; avoid in severe hepatic impairment.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInHepaticImpairment\">\n<sectiondiv>\n<p>In patients with pre-existing liver disease or hepatic impairment monitor liver function regularly and particularly frequently in the first 2 months.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39248\" outputclass=\"renalImpairment\" parent=\"/drugs/pyrazinamide\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>25&#8211;30&#8239;mg/kg 3 times a week if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>If estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, use 25&#8211;30&#8239;mg/kg 3 times a week.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"additionalMonitoringInRenalImpairment\">\n<sectiondiv>\n<p>Monitor for gout in renal impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39218\" outputclass=\"monitoringRequirements\" parent=\"/drugs/pyrazinamide\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>\n<i>Renal function</i> should be checked before treatment.</p>\n<p>\n<i>Hepatic function</i> should be checked before treatment. If there is no evidence of liver disease (and pre-treatment liver function is normal), further checks are only necessary if the patient develops fever, malaise, vomiting, jaundice or unexplained deterioration during treatment.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>Those with alcohol dependence should have frequent checks of hepatic function, particularly in the first 2 months.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58397\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.10\" parent=\"/drugs/pyrazinamide\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>In general, doses should be rounded up to facilitate administration of suitable volumes of liquid or an appropriate strength of tablet. Doses may also need to be recalculated to allow for weight gain in younger children.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP39256\" outputclass=\"patientAndCarerAdvice\" rev=\"1.19\" parent=\"/drugs/pyrazinamide\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Pyrazinamide for treatment of tuberculosis</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/pyrazinamide-for-tuberculosis\">www.medicinesforchildren.org.uk/pyrazinamide-for-tuberculosis</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"title\">Hepatic disorders</p>\r\n<p>Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise or jaundice develop.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP3612-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/pyrazinamide\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75024\" title=\"Tablet\" namespace=\"/drugs/pyrazinamide/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85621\" namespace=\"/drugs/isoniazid-with-pyrazinamide-and-rifampicin\" title=\"ISONIAZID WITH PYRAZINAMIDE AND RIFAMPICIN\" count=\"1\" rel=\"backlink\">ISONIAZID WITH PYRAZINAMIDE AND RIFAMPICIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP97002\" namespace=\"/drugs/ethambutol-with-isoniazid-pyrazinamide-and-rifampicin\" title=\"ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN\" count=\"1\" rel=\"backlink\">ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78330\" namespace=\"/treatment-summaries/tuberculosis\" title=\"Tuberculosis\" count=\"5\" rel=\"backlink\">Tuberculosis</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_192\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/pyrazinamide\" title=\"Pyrazinamide\" count=\"1\" rel=\"link\">Pyrazinamide</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75024\" namespace=\"/drugs/pyrazinamide/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP3612",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/pyrazinamide",
    "basename": "pyrazinamide",
    "title": "PYRAZINAMIDE",
    "interactants": [
        {
            "id": "bnf_int_192",
            "label": "Pyrazinamide"
        }
    ],
    "vtmid": "13592004",
    "drugClassification": [
        "Antimycobacterials"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Tuberculosis in combination with other drugs (standard unsupervised 6-month treatment)",
                        "html": "Tuberculosis in combination with other drugs (standard unsupervised 6-month treatment)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "35 mg/kg once daily for 2 months (initial phase); maximum 1.5 g per day.",
                        "html": "<p>35&#8239;mg/kg once daily for 2 months (initial phase); maximum 1.5&#8239;g per day.</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "35 mg/kg once daily for 2 months (initial phase); maximum 2 g per day.",
                        "html": "<p>35&#8239;mg/kg once daily for 2 months (initial phase); maximum 2&#8239;g per day.</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "1.5 g once daily for 2 months (initial phase).",
                        "html": "<p>1.5&#8239;g once daily for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "2 g once daily for 2 months (initial phase).",
                        "html": "<p>2&#8239;g once daily for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Tuberculosis in combination with other drugs (intermittent supervised 6-month treatment) (under expert supervision)",
                        "html": "Tuberculosis in combination with other drugs (intermittent supervised 6-month treatment) (under expert supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "50 mg/kg 3 times a week (max. per dose 2 g 3 times a week) for 2 months (initial phase).",
                        "html": "<p>50&#8239;mg/kg 3 times a week (max. per dose 2&#8239;g 3 times a week) for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "50 mg/kg 3 times a week (max. per dose 2.5 g 3 times a week) for 2 months (initial phase).",
                        "html": "<p>50&#8239;mg/kg 3 times a week (max. per dose 2.5&#8239;g 3 times a week) for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ],
                "adult": [
                    {
                        "textContent": "2 g 3 times a week for 2 months (initial phase).",
                        "html": "<p>2&#8239;g 3 times a week for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight up to 50 kg)"
                    },
                    {
                        "textContent": "2.5 g 3 times a week for 2 months (initial phase).",
                        "html": "<p>2.5&#8239;g 3 times a week for 2 months (initial phase).</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Acute attack of gout in adults",
                "html": "Acute attack of gout in adults",
                "specificity": {
                    "patientType": "adults"
                }
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Diabetes",
                "html": "Diabetes"
            },
            {
                "type": "cautions",
                "textContent": "gout in adults",
                "html": "gout in adults",
                "specificity": {
                    "patientType": "adults"
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (pyrazinamide).",
                "html": "<p>Appendix 1 (pyrazinamide).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Anorexia",
                        "html": "Anorexia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "arthralgia",
                        "html": "arthralgia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dysuria",
                        "html": "dysuria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fever",
                        "html": "fever",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flushing in adults",
                        "html": "flushing in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known",
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hepatomegaly",
                        "html": "hepatomegaly",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hepatotoxicity",
                        "html": "hepatotoxicity",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "liver failure",
                        "html": "liver failure",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "sideroblastic anaemia",
                        "html": "sideroblastic anaemia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "splenomegaly",
                        "html": "splenomegaly",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombocytopenia",
                        "html": "thrombocytopenia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Amount too small to be harmful.",
                "html": "<p>Amount too small to be harmful.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Idiosyncratic hepatotoxicity more common; avoid in severe hepatic impairment.",
                "html": "<p>Idiosyncratic hepatotoxicity more common; avoid in severe hepatic impairment.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "In patients with pre-existing liver disease or hepatic impairment monitor liver function regularly and particularly frequently in the first 2 months.",
                "html": "<p>In patients with pre-existing liver disease or hepatic impairment monitor liver function regularly and particularly frequently in the first 2 months.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "25&#8211;30 mg/kg 3 times a week if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>25&#8211;30&#8239;mg/kg 3 times a week if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "If estimated glomerular filtration rate less than 30 mL/minute/1.73 m2, use 25&#8211;30 mg/kg 3 times a week.",
                "html": "<p>If estimated glomerular filtration rate less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, use 25&#8211;30&#8239;mg/kg 3 times a week.</p>"
            }
        ],
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Monitor for gout in renal impairment.",
                "html": "<p>Monitor for gout in renal impairment.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Renal function should be checked before treatment.\n\nHepatic function should be checked before treatment. If there is no evidence of liver disease (and pre-treatment liver function is normal), further checks are only necessary if the patient develops fever, malaise, vomiting, jaundice or unexplained deterioration during treatment.",
                "html": "<p>\n<i>Renal function</i> should be checked before treatment.</p><p>\n<i>Hepatic function</i> should be checked before treatment. If there is no evidence of liver disease (and pre-treatment liver function is normal), further checks are only necessary if the patient develops fever, malaise, vomiting, jaundice or unexplained deterioration during treatment.</p>"
            },
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "Those with alcohol dependence should have frequent checks of hepatic function, particularly in the first 2 months.",
                "html": "<p>Those with alcohol dependence should have frequent checks of hepatic function, particularly in the first 2 months.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "In general, doses should be rounded up to facilitate administration of suitable volumes of liquid or an appropriate strength of tablet. Doses may also need to be recalculated to allow for weight gain in younger children.",
                "html": "<p>In general, doses should be rounded up to facilitate administration of suitable volumes of liquid or an appropriate strength of tablet. Doses may also need to be recalculated to allow for weight gain in younger children.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/pyrazinamide-for-tuberculosis",
                        "label": "www.medicinesforchildren.org.uk/pyrazinamide-for-tuberculosis"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Pyrazinamide for treatment of tuberculosis",
                "textContent": "www.medicinesforchildren.org.uk/pyrazinamide-for-tuberculosis",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/pyrazinamide-for-tuberculosis\">www.medicinesforchildren.org.uk/pyrazinamide-for-tuberculosis</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "title": "Hepatic disorders",
                "textContent": "Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise or jaundice develop.",
                "html": "<p>Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise or jaundice develop.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75024",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85621",
                "label": "ISONIAZID WITH PYRAZINAMIDE AND RIFAMPICIN",
                "type": "drug"
            },
            {
                "id": "PHP97002",
                "label": "ETHAMBUTOL WITH ISONIAZID, PYRAZINAMIDE AND RIFAMPICIN",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78330",
                "label": "Tuberculosis",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_192",
                "label": "Pyrazinamide",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75024",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}